ERNA Insider Trading Activity and SEC Form 4 Filings
ERNA insider trading summary
Over the past 12 months, insiders at Ernexa Therapeutics Inc. (ERNA) reported 1 open-market purchase worth $2.0M by 1 insider and no sales on SEC Form 4. Net insider buying was $2.0M.
Latest ERNA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 10, 2026 | Charles Cherington | 10% Owner | Buy | $2.0M (4,000,000 @ $0.50) |
| Jun 9, 2025 | Charles Cherington | 10% Owner | Buy | $2.2M (21,241,163 @ $0.10) |
| Apr 2, 2025 | Charles Cherington | 10% Owner | Buy | $394K (3,768,397 @ $0.10) |
| Oct 29, 2024 | Charles Cherington | 10% Owner | Buy | $0 (1,237,762 @ $0.00) |
| Oct 29, 2024 | Charles Cherington | 10% Owner | Buy | $0 (5,420,823 @ $0.00) |
| Oct 29, 2024 | Charles Cherington | 10% Owner | Buy | $0 (1,562,988 @ $0.00) |
| Oct 29, 2024 | Charles Cherington | 10% Owner | Buy | $0 (4,768,783 @ $0.00) |
| Oct 29, 2024 | Charles Cherington | 10% Owner | Buy | $0 (261,756 @ $0.00) |
| Dec 2, 2022 | Nicholas Jason Singer | Insider | Buy | $697K (212,464 @ $3.28) |
| Dec 2, 2022 | Nicholas Jason Singer | Insider | Buy | $232K (70,822 @ $3.28) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.